Novozymes (Denmark)

Novozymes (Denmark)

Novozymes A/S is a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus is the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novozymes (Denmark), Denmark, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

44%


Total
Publications

1.5K


Total Open
Publications

637


Total
Citations

67K


Open Access
Percentage

44%


Total
Publications

1.5K


Total Open
Publications

637


Total
Citations

67K

Wikipedia

Website

download

Breakdown

9% 22% 12% 57%

Publisher Open

9%

Both

22%

Other Platform Open

12%

Closed

57%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

181

Hybrid 34%

157

No Guarantees 27%

122

Other Platform Open

Domain 65%

326

Institution 58%

294

Other Internet 12%

60

Public 10%

51

Preprint 8%

40

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
329
Europe PMC
Domain
256
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit
Institution
214
University of Copenhagen - Research at the University of Copenhagen
Institution
37
Semantic Scholar
Public
36
Roskilde University - RUCforsk
Institution
29
bioRxiv
Preprint
24
Spanish National Research Council (CSIC) - DIGITAL.CSIC
Institution
20
whiterose.ac.uk OAI-PMH Repository
Institution
15
University of Leeds, The University of Sheffield, University of York - White Rose Research Online
Institution
14
1 / 13

Data updated 15 November 2023

Share

Share

Share